Chris Paquette of DeepIntent Named 2020 PM360 Trailblazer Vanguard Award Winner
PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Chris Paquette, Founder & CEO, DeepIntent as the 2020 Trailblazer Vanguard Award winner.
Read MoreDeepIntent Announces First CTV Marketplace for Pharma & Healthcare Marketers
The healthcare-specialized CTV Marketplace is fully integrated with DeepIntent’s healthcare audiences, so advertisers can reach their custom Patient and HCP audiences immediately with CTV ads
Read MoreDeepIntent Unveils Precise & Privacy-Safe Patient Targeting Solution
Today DeepIntent unveiled Patient Modeled Audiences, the only HIPAA-certified solution that allows advertisers to reach highly qualified patient audiences with speed and precision, in a privacy-compliant way
Read MoreDeepIntent’s Growth Continues with New Hires & Promotions
DeepIntent's success and growth continues. The company announced several new hires and executive promotions, as well as plans to to fill at least 16 new roles across the sales, ad operations, strategy, engineering, and data science teams in Q3 2020
Read MoreDeepIntent Launches Data-Rich & Privacy-Safe Healthcare Marketplace
Today DeepIntent launched its Healthcare Marketplace. Now healthcare advertisers & publishers can conduct direct, 1:1 trading within a data-rich and privacy-safe digital marketplace for healthcare advertising
Read MoreDeepIntent Launches MarketMatch™ for Advertisers to Unify HCP Planning & Activation
Today DeepIntent launched MarketMatch™ for Advertisers, the first end-to-end programmatic advertising solution for healthcare. Now marketers can act with the speed and precision needed to engage HCPs as they consider treatment options
Read MoreDeepIntent Expands its Healthcare Division with Key New Hires
DeepIntent continues to expand its New York City headquarters with the expansion of its Healthcare Division, sourcing top talent from Time, Inc. and Publicis Media
Read More
